Neutrogena
This article was originally published in The Tan Sheet
Executive Summary
Announces Aug. 10 it is "engaged in discussions" to be acquired by a "substantially larger company." The specialty skin care products marketer did not identify its potential suitor and said that "no agreements have been reached, nor have the companies' respective boards approved any transaction." The statement was issued by Neutrogena following a surge in its stock price earlier in the day to correct a statement made by Chief Financial Officer Donald Schort that there was no news pending to explain the increase in trading. Following the announcement, Neutrogena's stock jumped to a closing price of 26-3/4 on Friday, Aug. 12, up 5-1/8, from 21-5/8 prior to the announcement
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning